03 Profile
Vital Signsby Bridgehead
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Rare diseases
Channa Debruyne: no licensed photograph is held, so the sector leader plate is shown instead.
Sector leader
Channa Debruyne
global clinical development lead, late-stage and LCM oncology, at Servier
1
0
0
0
0
0
0
0
0
0
0
0
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
1
press citation on 1 topic since 9 Dec 2025 · last quoted 9 Dec 2025
02 Quoted on · 1 of 29 topics
Channa Debruyne: key facts
- Kind of voice
- Sector leader
- Role
- global clinical development lead, late-stage and LCM oncology, at Servier
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 9 Dec 2025
04 The signal · where Channa Debruyne sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Evgeniya ShapiroSector leaderCEO of PSK Pharma1
- 25=Yuri ZhulevSector leaderco-chair of the All-Russian Union of Patients1
- 25=Channa DebruyneSector leaderglobal clinical development lead, late-stage and LCM oncology, at Servier1
- 25=Clara Cali MellaSector leaderdata strategy lead at Bayer1
- 25=Eslam KatabSector leaderglobal clinical development manager at Sandoz1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Channa Debruyne has said
By outlet · linked articles
- clinicaltrialsarena.com1
Where Channa Debruyne has been quoted
- 01Utilising real-world data to overcome challenges in rare disease researchclinicaltrialsarena.com · 9 Dec 2025
Verbatim
“real-world data from similar patient populations to those in a study cohort can be utilised as a comparator. The data should preferably be at the patient level and populations should be matched in terms of key demographics and prognostic baseline variables”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.